Skip to main content
Equibles

Mariann Ohanesian

Puma Biotechnology, Inc. (PBYI)

Equibles does not estimate personal net worth.

Get an email with a short summary when Puma Biotechnology, Inc. publishes a filing, an earnings call transcript or a press release.

Get PBYI alerts

About Mariann Ohanesian

Mariann Ohanesian has spoken on 9 earnings calls and 1 other investor event across 1 company, most recently for Puma Biotechnology, Inc. on November 5, 2026. Puma Biotechnology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Puma Biotechnology, Inc. includes Alan Auerbach (CEO and Board Member), Alan H. Auerbach (CEO and Board Member), Maximo Nougues (CFO) and 7 others.

Mariann Ohanesian on recent calls

“Good afternoon, and welcome to Puma's conference call to discuss our earnings results for the third quarter of 2026.”
Head of Investor Relations, November 5, 2026 - Puma Biotechnology 3Q-2026 Financial Results Conference Call ·
“Good afternoon, and welcome to Puma's conference call to discuss our earnings results for the second quarter of 2026.”
Head of Investor Relations, Sept. 14, 2026 - H.C. Wainwright 28th Annual Global Investment Conference ·
“Good afternoon, and welcome to Puma's conference call to discuss our earnings results for the second quarter of 2026.”
Head of Investor Relations, August 6, 2026 - Puma Biotechnology 2Q-2026 Financial Results Conference Call ·
“Good afternoon and welcome to Puma's conference call to discuss our results for the first quarter of 2026.”
Head of Investor Relations, Puma Biotechnology, Inc. Q1 FY2026 Earnings Call ·
“Good afternoon and welcome to Puma's conference call to discuss our earnings results for the first quarter of 2025.”
Head of Investor Relations, Puma Biotechnology, Inc. Q1 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Puma Biotechnology, Inc.

Recent activity